Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
作者信息
Langer Robert D
出版信息
Am J Epidemiol. 2009 Mar 15;169(6):784-5; author reply 785-6. doi: 10.1093/aje/kwn420. Epub 2009 Feb 10.
PMID:19208722
Abstract
摘要
相似文献
1
Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.关于：近期绝经后妇女的雌激素加孕激素疗法与乳腺癌
Am J Epidemiol. 2009 Mar 15;169(6):784-5; author reply 785-6. doi: 10.1093/aje/kwn420. Epub 2009 Feb 10.
2
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度：妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
3
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.醋酸甲羟孕酮对雌激素依赖性风险和益处的影响——解读女性健康倡议结果的尝试。
Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.
4
Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.关于：共轭马雌激素与良性增生性乳腺疾病风险：一项随机对照试验。
J Natl Cancer Inst. 2008 Sep 17;100(18):1335; author reply 1335-6. doi: 10.1093/jnci/djn277. Epub 2008 Sep 9.
5
Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource. 2011 Mar;15(3):3.
6
The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.妇女健康倡议雌激素加孕激素试验：研究及其对我们临床实践的影响。
J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S3-5.
7
[Hormone replacement therapy in menopause].
Dtsch Med Wochenschr. 2003 Feb 21;128(8):400. doi: 10.1055/s-2003-37374.
8
Women's health. The vanishing promises of hormone replacement.女性健康。激素替代疗法渐逝的承诺。
Science. 2002 Jul 19;297(5580):325-6. doi: 10.1126/science.297.5580.325.
9
New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.迫切需要有关激素替代疗法的新证据，经皮绝经后激素疗法在风险和益处方面与口服激素疗法不同。
Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003.
10
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.雌激素加孕激素联合使用时，健康风险大于益处。一项主要研究提前终止了临床试验。
Ginecol Obstet Mex. 2002 Aug;70:411-2.
Zotero 插件